Fluoroquinolones like ciprofloxacin are the most widely recommended first-line antibiotics for serious Salmonella infections in adults, with extended-spectrum cephalosporins such as ceftriaxone and azithromycin serving as key alternatives. But the choice of antibiotic depends heavily on which type of Salmonella infection you’re dealing with, how severe it is, and whether the strain involved has developed resistance to commonly used drugs. That last factor has become a growing concern, with some strains now resistant to nearly every conventional option.
Most Salmonella Infections Don’t Need Antibiotics at All
This surprises a lot of people, but the majority of nontyphoidal Salmonella cases, the kind you get from contaminated food, resolve on their own within four to seven days without any antibiotic treatment. Symptoms like diarrhea, fever, and cramping are unpleasant but self-limiting in otherwise healthy adults. Antibiotics aren’t just unnecessary in these cases; they can actually cause harm. One outbreak study found that people who received antibiotics shed the bacteria in their stool for longer than those who weren’t treated.1PubMed Central. Fecal excretion of Salmonella enterica serovar typhimurium following a food-borne outbreak A separate study examining fecal excretion over three months found no benefit from antibiotic treatment at any time point compared to untreated controls.2PubMed. Role of antibiotic therapy on long-term germ excretion in faeces and digestive symptoms after Salmonella infection
The standard approach for uncomplicated gastroenteritis is supportive care: fluids, rest, and electrolyte replacement. Antibiotics become necessary when the infection moves beyond the gut, entering the bloodstream (bacteremia), infecting bones (osteomyelitis), or settling into other organs. They’re also warranted for people at high risk of these complications, including infants, older adults, people with weakened immune systems, and those with conditions like sickle cell disease. And they’re essential for typhoid and paratyphoid fever, which are caused by different Salmonella species and behave quite differently from typical food poisoning.
First-Line Antibiotics for Invasive Salmonella Disease
When an antibiotic is needed for a serious nontyphoidal Salmonella infection in an adult, ciprofloxacin is the standard first choice. Alternative options include other fluoroquinolones like levofloxacin and moxifloxacin, as well as cotrimoxazole (trimethoprim-sulfamethoxazole) and the extended-spectrum cephalosporins ceftriaxone and cefotaxime.3PubMed Central. Antimicrobial resistance and management of invasive Salmonella disease The reason fluoroquinolones lead the pack is partly pharmacological: they penetrate well into tissues and, crucially, into the cells where Salmonella hides. Lab studies have shown that fluoroquinolones and newer macrolides are more effective than other drug classes at killing Salmonella inside human immune cells.4PubMed. In vitro evaluation of intracellular activity of antibiotics against non-typhoid Salmonella
That intracellular survival matters more than you might think. Salmonella can persist inside macrophages, a type of white blood cell, essentially using the body’s own immune system as a hiding spot. The bacteria can sit dormant inside these cells, evade the immune response, dodge antibiotic exposure, and later re-emerge to cause infection again.5PubMed Central. Nifuratel reduces Salmonella survival in macrophages by extracellular and intracellular antibacterial activity This is one reason why Salmonella infections sometimes relapse after what seemed like successful treatment, and why the antibiotic chosen needs to be one that reaches adequate levels inside those cells, not just in the blood.
Treating Typhoid and Paratyphoid Fever
Typhoid fever, caused by Salmonella Typhi, is a different clinical situation from the garden-variety food poisoning most people associate with Salmonella. It’s a systemic illness with sustained high fever, and it always requires antibiotic treatment. For decades, the classic regimen was chloramphenicol, ampicillin, or trimethoprim-sulfamethoxazole. These drugs worked well for most of the 20th century, but widespread resistance eventually rendered them unreliable in many parts of the world.6PubMed. Multidrug resistance in Salmonella enterica serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria
As those older drugs lost effectiveness, fluoroquinolones like ciprofloxacin became the go-to treatment for typhoid in the 1990s and 2000s. They remain effective in many regions, but resistance has crept into fluoroquinolones too. Azithromycin has emerged as another oral option, though head-to-head comparisons show it works somewhat differently. In a controlled human infection study, people treated with ciprofloxacin cleared Salmonella Typhi from their blood far faster than those treated with azithromycin, with a median time to clearance of about 20 hours for ciprofloxacin versus roughly 91 hours for azithromycin.7PubMed Central. Treatment responses to Azithromycin and Ciprofloxacin in uncomplicated Salmonella Typhi infection: A comparison of Clinical and Microbiological Data from a Controlled Human Infection Model Despite that slower clearance, azithromycin remains an important oral option, especially where fluoroquinolone resistance is common.
Why Treatment in Children Looks Different
The antibiotic toolkit for children with invasive Salmonella infections is more limited than it is for adults. Fluoroquinolones like ciprofloxacin have historically not been approved for routine pediatric use due to concerns about effects on developing joints and cartilage. That makes ceftriaxone, given intravenously or intramuscularly, the primary drug of choice for serious Salmonella infections in kids.8New England Journal of Medicine. Ceftriaxone-Resistant Salmonella Infection Acquired by a Child from Cattle Azithromycin serves as an oral alternative, particularly for typhoid.
This narrower set of options makes resistance in children a particularly serious problem. When a Salmonella strain is resistant to ceftriaxone and fluoroquinolones aren’t a viable choice, clinicians face difficult decisions. The emergence of ceftriaxone-resistant strains among children has been documented and is driven largely by bacteria that produce enzymes capable of breaking down cephalosporin drugs.9PubMed Central. Prevalence and Characteristics of Ceftriaxone-Resistant Salmonella in Children’s Hospital in Hangzhou, China In those situations, clinicians may have to turn to carbapenems, a class of last-resort antibiotics typically reserved for the most resistant infections.
Sickle Cell Disease and Bone Infections
People with sickle cell disease face a specific and well-known vulnerability: Salmonella is one of the most common causes of bone infection (osteomyelitis) in this population. The treatment landscape for Salmonella osteomyelitis has shifted over time. Chloramphenicol, ampicillin, and trimethoprim-sulfamethoxazole were used most frequently in earlier decades, but newer beta-lactams and quinolones have proven more active against the bacteria.10Seminars in Arthritis and Rheumatism. Salmonella osteomyelitis and arthritis in sickle cell disease When Salmonella infection leads to septic arthritis rather than osteomyelitis, the outlook is generally worse, and aggressive surgical drainage is often needed alongside antibiotics.
The Collapse of Older Drug Regimens
Understanding why certain antibiotics are recommended today requires knowing what happened to the ones that came before. Chloramphenicol was the original mainstay of typhoid treatment from the 1940s onward. Ampicillin and trimethoprim-sulfamethoxazole joined it as alternatives. For decades, these three drugs formed the backbone of Salmonella treatment worldwide. Then multidrug-resistant (MDR) strains began to appear, defined as Salmonella resistant to all three of those first-line agents simultaneously. Surveillance data from endemic regions has confirmed that the effectiveness of these older drugs is now unreliable in many settings.6PubMed. Multidrug resistance in Salmonella enterica serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria
This forced the shift to fluoroquinolones and cephalosporins during the 1990s. But the warning signs that resistance would eventually catch up with these newer drugs appeared early. Researchers flagged the emergence of Salmonella strains resistant to both fluoroquinolones and third-generation cephalosporins as a likely future problem well before it became widespread.11Clinical Infectious Diseases. Nontyphoidal Salmonellosis That prediction has largely come true.
How Salmonella Develops Antibiotic Resistance
Salmonella acquires resistance through two main routes. The first involves spontaneous mutations in the bacterial DNA, particularly in genes that code for the proteins targeted by antibiotics. For fluoroquinolones, the key genes are called gyrA and parC. Mutations in these genes change the shape of the proteins that fluoroquinolones are designed to latch onto, making the drug unable to recognize its target.12PubMed. The molecular mechanisms of quinolone resistance in Salmonella: a review A study of Salmonella isolates from human infections in Poland identified over 120 such mutations among fewer than 100 bacterial samples, showing how common these changes have become.13PubMed Central. The Mechanisms Involved in the Fluoroquinolone Resistance of Salmonella enterica Strains Isolated from Humans in Poland, 2018-2019: The Prediction of Antimicrobial Genes by In Silico Whole-Genome Sequencing
The second route is arguably more dangerous: bacteria can acquire resistance genes from other bacteria through mobile genetic elements, essentially swapping resistance traits horizontally. For ceftriaxone resistance, the main culprits are genes that produce enzymes called extended-spectrum beta-lactamases (ESBLs), which chemically dismantle cephalosporin drugs before they can work. A surveillance study of over 3,000 Salmonella samples from humans, animals, food, and water in Shanghai found that ceftriaxone resistance rose from about 5% to over 8% in just two years, and nearly all resistant isolates were confirmed ESBL producers.14PubMed. Increase in Ceftriaxone Resistance and Widespread Extended-Spectrum β-Lactamases Genes Among Salmonella enterica from Human and Nonhuman Sources These resistance genes can jump between bacteria of different species, meaning Salmonella can pick up resistance from completely unrelated bacteria sharing the same environment.
Extensively Drug-Resistant Typhoid
The most alarming development in Salmonella treatment has been the emergence of extensively drug-resistant (XDR) strains of Salmonella Typhi. XDR typhoid is resistant not just to the three classical first-line drugs but also to fluoroquinolones and third-generation cephalosporins. That eliminates nearly every standard oral and intravenous option. These strains have been spreading in Pakistan and have been reported in travelers returning to other countries. For XDR typhoid, the remaining treatment options are essentially azithromycin (if the strain is still susceptible) and carbapenems, which are expensive, require intravenous administration, and represent some of the last antibiotics available for gram-negative bacterial infections.15PubMed Central. Rising XDR-Typhoid Fever Cases in Pakistan: Are We Heading Back to the Pre-antibiotic Era?
The concern isn’t academic. If azithromycin resistance develops in these already-XDR strains, or if carbapenem resistance genes make the jump into Salmonella Typhi, physicians in affected regions would have virtually no effective treatment. This scenario has been described frankly in the medical literature as a potential return to pre-antibiotic-era conditions for typhoid fever.
Treating Chronic Carriers
Most people clear Salmonella within weeks, but a small percentage become chronic carriers who shed the bacteria in their stool for months or even years without feeling sick. Typhoid fever is the classic setting for this: about 1 to 5 percent of people who recover from typhoid become long-term carriers, with the bacteria taking up residence in the gallbladder. These carriers can unknowingly spread the infection to others.
Eradicating the carrier state is harder than treating acute illness. A systematic review of antimicrobial agents for clearing enteric fever carriage found that fluoroquinolones were significantly more effective than ampicillin or amoxicillin, with about 92% of patients achieving eradication after one course of a fluoroquinolone compared to roughly 68% with ampicillin-type drugs.16PubMed Central. Antimicrobial agents for the treatment of enteric fever chronic carriage: A systematic review Even so, some carriers require cholecystectomy (surgical removal of the gallbladder) when antibiotics fail, because the gallstones that often accompany chronic carriage provide a protected environment where bacteria can persist despite drug treatment.
The Role of Susceptibility Testing
Given the complicated resistance landscape, blind prescribing for Salmonella is increasingly risky. Laboratory-based antimicrobial susceptibility testing remains the foundation for guiding treatment and tracking resistance patterns.17PubMed Central. Whole-Genome Sequencing for Detecting Antimicrobial Resistance in Nontyphoidal Salmonella In practice, this means growing the bacteria from a patient’s blood or stool sample and then testing which antibiotics can kill it in the lab. The results can take a day or two, so doctors treating severely ill patients often start with empiric therapy (the best guess based on local resistance data) and then adjust once test results come back.
Whole-genome sequencing is increasingly being used alongside traditional culture-based methods. It can identify known resistance genes directly from the bacterial DNA, sometimes faster than waiting for the organism to grow in the presence of various antibiotics. It’s especially useful for surveillance purposes, helping public health authorities track which resistance genes are circulating in a population and whether new ones are emerging.
Agricultural Antibiotic Use and Its Consequences
A significant share of the resistance problem can be traced to antibiotic use in livestock. Salmonella circulates freely in poultry, cattle, and pigs, and when animals are given antibiotics, either to treat illness or to promote growth, the Salmonella in their guts faces the same selective pressure that drives resistance in human medicine. Multidrug-resistant Salmonella that arises in food animals can transfer to humans through the food chain, creating a direct pipeline from farm to human infection.18PubMed Central. Antibiotic-Resistant Salmonella in Animal Products Jeopardize Human Health
The case of ceftriaxone-resistant Salmonella acquired by a child from cattle contact illustrates the point in stark terms: a drug considered the primary option for invasive Salmonella disease in children was rendered useless by resistance that developed in an agricultural setting.8New England Journal of Medicine. Ceftriaxone-Resistant Salmonella Infection Acquired by a Child from Cattle Several countries have moved to restrict antibiotic use in food animals, but enforcement and global adoption remain uneven. In the meantime, the resistance genes continue to spread between animal and human Salmonella populations.
Phage Therapy as an Emerging Alternative
With the antibiotic pipeline narrowing, researchers have been looking at older ideas with fresh eyes. Bacteriophages, viruses that specifically infect and kill bacteria, have gained renewed attention as a potential tool against multidrug-resistant Salmonella. The concept isn’t new; phage therapy was explored in the early 20th century before antibiotics overshadowed it. What’s changed is the urgency.
Experimental studies have demonstrated that phage therapy can effectively control Salmonella in animal models. Safety and efficacy trials in poultry have been particularly active, since Salmonella is such a pervasive problem in the poultry industry.19PubMed Central. Use of Phages to Treat Antimicrobial-Resistant Salmonella Infections in Poultry One recently characterized phage showed strong stability across wide temperature and pH ranges, carried no genes for virulence or antibiotic resistance in its own genome, and provided effective protection to broiler chickens when given as a single oral dose shortly after Salmonella exposure.20PubMed Central. Characterization, genome analysis, and therapeutic evaluation of a novel Salmonella phage vB_SalS_JNS02: a candidate bacteriophage for phage therapy Lab evaluations of lytic phages against multidrug-resistant Salmonella Typhimurium have also yielded promising results, though the leap from laboratory findings to approved human therapeutics remains a significant one.21PubMed Central. Evaluation of lytic bacteriophages for control of multidrug-resistant Salmonella Typhimurium
Phages have some inherent advantages over conventional antibiotics. Each phage targets a narrow range of bacterial hosts, meaning it can attack the offending Salmonella strain while leaving beneficial gut bacteria largely undisturbed. They’re also self-replicating at the site of infection, so in theory the dose increases where it’s needed most. The main limitations are practical: phages are highly specific, so a cocktail of multiple phages is often needed to cover the range of strains circulating in a given setting, and regulatory frameworks for approving phage-based treatments in humans are still catching up. For now, phage therapy for Salmonella in humans remains experimental, but its development in agricultural settings could reduce the reservoir of resistant bacteria that eventually threatens human medicine.